Invicta Diagnostic IPO
Invicta Diagnostic IPO is an SME IPO, the company will raise up to 33,08,800 shares (Aggregating up to ₹28.12 crore) via this IPO. The IPO comprises a fresh issue of 33,08,800 shares (Aggregating up to ₹28.12 crore), and an offer for sale (OFS) of shares (amount) NIL.
Invicta Diagnostic IPO will open for subscription on 1 December 2025 and close on 3 December 2025. Basis of Allotment will be decided on 4 December 2025, initiation of refund will begin on 5 December 2025 and finally IPO will be listed on 8 December 2025 at NSE SME. Socradamus Capital Pvt Ltd is the book running lead manager and Bigshare Services Pvt Ltd is the registrar of the Invicta Diagnostic IPO.
Total shares offered by Invicta Diagnostic IPO is 33,08,800 shares (Aggregating up to ₹28.12 crore). Out of which Not less than 35% of the net offer is reserved for retail, Not less than 15% of the net offer is reserved for HNI (NII), Not more than 50% of the net offer is reserved for QIB, and - is reserved for market maker .
Invicta Diagnostic IPO Price Band and Market Lot
Invicta Diagnostic has set a price band of ₹80 to ₹85 per share and lot size is of 1,600 shares. Retail investors can bid for a minimum and maximum of 2 lots (3,200 shares), requiring an investment of ₹2,72,000, sHNI investors can bid for a minimum of 3 lots (4,800 shares), requiring an investment of ₹4,08,000 and bHNI investors can bid for a minimum of 8 Lots (12,800 shares), requiring an investment of ₹10,88,000 calculated at the cut-off price ₹85 per share (the upper end of the price band).
Invicta Diagnostic IPO GMP (Grey Market Premium)
Visit us daily to get the latest update on Invicta Diagnostic IPO GMP. Invicta Diagnostic SME IPO GMP started, and here you can get the latest update of Invicta Diagnostic SME IPO GMP.
Invicta Diagnostic IPO GMP today or grey market premium and the Latest GMP Data pattern is available here.
- Price Band of Invicta Diagnostic IPO is ₹80 to ₹85 per share.
- Current GMP (Grey Market Premium) for Invicta Diagnostic IPO is:
- It is a premium for the Invicta Diagnostic IPO cut-off price ₹85 per share.
| Invicta Diagnostic SME IPO GMP | ||
| Date | GMP (₹) | Listing Price (₹-Estimated) |
| Today | 0 | |
| 27 November 2025 | 0 | |
| 26 November 2025 | 0 | |
| 25 November 2025 | 0 | |
| Invicta Diagnostic IPO Time Table (Tentative) | |
| IPO Open Date | 1 December 2025 |
| IPO Close Date | 3 December 2025 |
| Basis of Allotment Date | 4 December 2025 |
| Initiation of Refunds | 5 December 2025 |
| Credit of Share to Demat Account | 5 December 2025 |
| IPO Listing Date | 8 December 2025 |
| IPO Cut-off time (UPI mandate confirmation) | 5:00 PM on 3 December 2025 |
| Invicta Diagnostic IPO Reservation | |
| Retail Quota | Not less than 35% of the net offer |
| NII Quota | Not less than 15% of the net offer |
| QIB Quota | Not more than 50% of the net offer |
| Market Maker Quota | - |
| Total | 33,08,800 shares (100%) |
| Invicta Diagnostic IPO Price | |
| Face Value | ₹10 per share |
| Price Band | ₹80 to ₹85 per share |
| Lot Size | 1,600 shares |
| IPO Issue Type | Book Built Issue |
About Invicta Diagnostic
Invicta Diagnostic Limited is an integrated diagnostic services provider operating under the brand name PC Diagnostics in the Mumbai Metropolitan Region. Incorporated in 2021, the company offers a comprehensive range of radiology and pathology services, including imaging, laboratory testing and teleradiology, through a hub‑and‑spoke network of multiple diagnostic centres and a centralised laboratory. Its portfolio covers hundreds of routine and specialised pathology tests along with basic and advanced radiology modalities such as X‑ray, ultrasound, CT, MRI and PET‑CT, supported by a technology driven workflow focused on accuracy, accessibility and patient convenience.
Invicta Diagnostic IPO Frequently Asked Questions
The latest Grey Market Premium (GMP) of Invicta Diagnostic IPO is .
It is a premium to the IPO cut-off price Invicta Diagnostic. GMP gives a rough estimate of the premium at which the stock might list. It’s not guaranteed but often aligns with market sentiment.
As per latest GMP data, the expected return for Invicta Diagnostic IPO can be .
Expected listing listing price for Invicta Diagnostic share can be .
According to latest GMP data pattern expected listing price and profit per share for Invicta Diagnostic IPO can be . Expected listing gain is calculated by adding the GMP to the the IPO issue price. Estimated listing price = IPO issue price + current GMP. This value changes as the GMP fluctuates.
GMP is an unofficial indicator and can be manipulated. It should never be the sole reason to apply. Always consider fundamentals and risk tolerance. Subscription demand, financial performance, market sentiment, peer valuation, and overall liquidity can impact the GMP trend.
Disclaimer:
- Grey market premium (GMP) indicates investors are willing to pay more than the issue price.
- A negative GMP suggests that the IPO’s share is likely to be listed on the stock exchange at a discount, and a positive Grey Market Premium suggests that the IPO’s share is likely to be listed on the stock exchange at a profit.
- Do not subscribe for Invicta Diagnostic IPO by just seeing the premium Price, It can change anytime
- We do not trade/deal or buy/sell Invicta Diagnostic IPO forms in the grey market and GMP prices shown here are gathered from various sources.